Researchers studying naked mole rats found a gene that drives high levels of high molecular weight hyaluronic acid, a molecule linked to cancer resistance, lower inflammation, and healthier aging. When scientists introduced the gene into mice, the animals showed improved health markers and a modest lifespan increase, reigniting interest in regenerative medicine.
Japanese researchers have begun human trials for a drug designed to regrow teeth by activating dormant tooth buds. The approach could offer a more natural path to treating tooth loss, moving beyond today’s implants and dentures. Early findings look promising, and the team is targeting a potential release around 2030 if results hold up.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Japanese researchers say a medicine designed to regrow teeth is moving toward human clinical trials. The breakthrough could shift dental care from treatment and replacement toward true regeneration, offering hope for people affected by decay and tooth loss. While early, the planned studies mark an important step from lab results to real-world testing in patients.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
